ECDC news release
An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhoea infection. Alongside growing evidence of the domestic spread of such resistant strains in Europe over the last two years, this poses a significant challenge for future treatment options for one of the most common sexually transmitted diseases worldwide, according to an assessment issued by the European Centre for Disease Prevention and Control (ECDC).
In the risk assessment, ECDC analyses the surge in ceftriaxone-resistant gonorrhoea infections across Europe since 2022 as well as related risks for sexually active people, based on reports from 11 European countries.
Access the full news release with the accompanying materials here.
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.